Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

We have generated a physiologically relevant bacterial artificial chromosome (BAC)-based genomic DNA expression model to study PS1 gene expression and function. The PS1-WT-BAC construct restored γ-secretase function, whereas the mutant PS1 BACs demonstrated partial to complete loss of enzymatic activity when stably expressed in a PS double knock-out clonal cell line. We then engineered WT and mutant human PS1-BAC-Luciferase whole genomic locus reporter transgenes, which we transiently transduced in mouse and human non-neuronal and neuronal-like cells, respectively. PS1 ΔE9 and C410Y FAD were found to lower PS1 gene expression in both cell lines, whereas PS1-M146V showed a neuron-specific effect. The nonclinical γ-secretase inactive PS1-D257A mutation did not alter gene expression in either cell line. This is the first time that pathogenic coding mutations in the PS1 gene have been shown to lower PS1 gene expression. These findings may represent a pathologic mechanism for PS1 FAD mutations independent of their effects on γ-secretase activity and demonstrate how dominant PS1 mutations may exert their pathogenic effects by a loss-of-function mechanism.

Original publication

DOI

10.1016/j.neurobiolaging.2013.07.026

Type

Journal article

Journal

Neurobiol Aging

Publication Date

02/2014

Volume

35

Pages

443.e5 - 443.e16

Keywords

Alzheimer's disease, Gene expression, Mutations, Alzheimer Disease, Amyloid Precursor Protein Secretases, Animals, Cell Line, Cercopithecus aethiops, Chromosomes, Artificial, Bacterial, Clone Cells, DNA, Bacterial, Gene Expression, Genes, Reporter, Genetic Loci, Genome, Bacterial, Humans, Luciferases, Bacterial, Mice, Models, Genetic, Mutation, Presenilin-1, Transgenes, Vero Cells